HKUST Celebrates 20 Awards at 48th International Exhibition of Inventions Geneva
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
[The content of this article has been produced by our advertising partner.]
The Hong Kong University of Science and Technology (HKUST) achieved a significant milestone at the 48th International Exhibition of Inventions Geneva, earning 20 awards for 19 groundbreaking inventions.
Highlights of the award-winning inventions include a biomarker-based detection system for assessing Alzheimer’s disease, advanced polymer-based therapeutics for chronic disease, metal 3D printing by ultrasonic excitation and active temperature control, as well as four innovative technologies on water treatment developed in tandem with the Drainage Services Department.
This marks HKUST’s first institutional participation in this prestigious international event. The recognition it received—a total of 20 awards—includes one Prize of the Chinese Delegation for Invention and Innovation, three Gold Medals with Congratulations of the Jury, five Gold Medals, six Silver Medals, and five Bronze Medals.
“We are proud that HKUST’s inventions and technologies have been well recognized at the International Exhibition of Inventions Geneva. It demonstrates our strong research capabilities on frontier research, which best positions us to help fill the gap by building a robust ecosystem from basic research to impact. Our success also shows the entrepreneurial spirit of our students, alumni, and faculties.,” said Professor Tim Cheng, HKUST Vice-President for Research and Development.
Inventive Projects Deliver Wide-Ranging Impact
HKUST’s winning projects encompass an expansive array of fields. The research project on assessing Alzheimer’s disease with protein biomarker panels led by HKUST President Professor Nancy Ip, won the Prize of the Chinese Delegation for Invention and Innovation and the Gold Medal with Congratulations of the Jury. The trailblazing biomarker-based detection system can identify Alzheimer’s disease five to ten years before symptoms manifest by detecting changes in blood biomarker levels.
Two other…